AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 79 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $28,187,000 | +8.5% | 2,824,403 | +3.6% | 0.15% | +7.8% |
Q1 2018 | $25,974,000 | -35.5% | 2,725,571 | +0.3% | 0.14% | -36.2% |
Q4 2017 | $40,292,000 | -32.4% | 2,716,167 | -10.8% | 0.22% | -35.4% |
Q3 2017 | $59,629,000 | +17.7% | 3,043,867 | -13.7% | 0.34% | +11.8% |
Q2 2017 | $50,664,000 | +55.1% | 3,525,685 | -0.7% | 0.31% | +49.3% |
Q1 2017 | $32,665,000 | -10.3% | 3,550,547 | +1.5% | 0.20% | -14.2% |
Q4 2016 | $36,428,000 | +14.6% | 3,499,357 | -0.4% | 0.24% | +10.6% |
Q3 2016 | $31,785,000 | +18.6% | 3,512,164 | -2.0% | 0.22% | +16.1% |
Q2 2016 | $26,801,000 | -22.2% | 3,583,061 | -6.2% | 0.19% | -22.2% |
Q1 2016 | $34,428,000 | -33.0% | 3,821,125 | -3.9% | 0.24% | -30.5% |
Q4 2015 | $51,394,000 | -18.6% | 3,977,894 | -39.1% | 0.34% | +59.3% |
Q3 2015 | $63,138,000 | +152.1% | 6,536,154 | +168.5% | 0.22% | +53.2% |
Q2 2015 | $25,045,000 | +82.0% | 2,434,013 | +96.5% | 0.14% | +78.5% |
Q1 2015 | $13,759,000 | -3.3% | 1,238,436 | +1.3% | 0.08% | -3.7% |
Q4 2014 | $14,231,000 | -26.8% | 1,222,631 | +39.2% | 0.08% | +46.4% |
Q3 2014 | $19,430,000 | – | 878,042 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alerce Investment Management, L.P. | 4,652,561 | $3,340,000 | 5.66% |
Orchard Capital Management, LLC | 1,762,731 | $1,265,000 | 0.36% |
Ikarian Capital, LLC | 1,200,000 | $860,000 | 0.11% |
Ikarian Capital, LLC | 800,000 | $575,000 | 0.08% |
XTX Topco Ltd | 102,392 | $74,000 | 0.03% |
Nantahala Capital Management | 965,800 | $693,000 | 0.03% |
Worth Venture Partners, LLC | 63,500 | $46,000 | 0.02% |
Ardent Capital Management, Inc. | 43,429 | $31,000 | 0.02% |
Virtus ETF Advisers LLC | 65,149 | $47,000 | 0.02% |
RICE HALL JAMES & ASSOCIATES, LLC | 513,292 | $368,000 | 0.02% |